NCBI PubMed Central
open access
RHEBL1 expression is activated by the Oct4-Sox2 complex in oral squamous cell carcinoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immunohistochemical Expression of SOX2 and OCT4 in Oral Squamous Cell Carcinoma: A Pilot Study#328834
- Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA#67893
- A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma#904660
- Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study#824019
- RNA-seq dataset: GB1275, a small-molecule agonist of cd11b, combined with drug-loaded oncolytic bacteria for pancreatic cancer therapy.#359847
Record · ID 308898
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive